MEETING OF THE QASDG CLINICAL RESEARCH SUBGROUP European Commission Initiative on Breast Cancer (ECIBC) Varese, ITALY, 22 November 2016.
|
|
- Melvyn Clark
- 5 years ago
- Views:
Transcription
1 EUROPEAN COMMISSION DIRECTORATE GENERAL JOINT RESEARCH CENTRE Directorate F Health, Consumers and Reference Materials Unit F1 Health in Society MEETING OF THE CLINICAL RESEARCH SUBGROUP European Commission Initiative on Breast Cancer (ECIBC) Varese, ITALY, 22 November 2016 Minutes Document history Version Date Drafted by Comments 0 06/12/2016 Silvia DEANDREA and Nadya DIMITROVA To be reviewed and approved by the participants 1 15/12/2016 Silvia DEANDREA Approved Page: 1 of 5
2 Tuesday 22 November :30 18:30 Clinical Research subgroup meeting List of participants is reported in ANNEX I The meeting was chaired by Giorgio STANTA Purpose of the meeting: To updated members of the Clinical Research subgroup on the outcomes of the teleconference between the subgroup's coordinator and the GDG Diagnosis subgroup editors (A. Lebeau, C. Quinn, P. Giorgi Rossi) and make decision on the steps forward. Giorgio Stanta made a presentation on the current perspectives of clinical research for breast cancer and also shared with the group the comments received by an absent subgroup member (Tibot Tot). The presentation is available on CIRCABC. The main points were: Identification of "second level centers": at European level the organisation of breast cancer care is very diverse. The participants to the meeting reported different experiences and models, from countries where all the centres must be able to treat every breast cancer case (e.g. Sweden) to contexts where the "comprehensive cancer centre" model is prevalent (e.g. OECI accreditation) to areas where a "hub-andspoke" model is applied. The group discussed also on the new perspectives offered by biobanks, that allows the possibility to have a tissue (sample/specimen) moving e.g to a reference centre, and not the patient. The underlined that a definition of an organisation model for breast cancer care at European level is out of the scope of this project, although it should be taken into account already from the piloting the possibility that some breast centres may not be able to treat specific breast cancer cases for several reasons: too complex, too costly, etc. Having a list of "special cases" for which it may be acceptable (or may be not) a referral to a second level centre would be useful already at this stage of the project Identification of breast cancer "special cases": the group discussed on the identification of these "special cases". Giorgio Stanta presented the opinion of Tibor Tot, stating that a meeting organised by the EC stated that breast cancer sarcomas and breast hematologic malignancies should be treated in second level institutions. Then the group discussed whether a predictors may be identified in order to select other kinds of breast cancer (e.g. in BRCA women, HER+ cases etc.) but without coming to a decision. It also seemed that a literature search on this topic would not be helpful. Then, the discussion moved to the identification of tests and technologies that should be provided in second level only and/or in structures with a special accreditation for this (e.g. OECI). Giorgio Stanta mentioned exome sequencing, plasma level DNA and liquid biopsies as test that may fall under this category. As accreditation of testing activities within the ECIBC is discussed in the Testing subgroup, the suggested bringing this proposal at that table. PICO question: the subgroup considered as relevant issuing a PICO question on the impact of clinical research on breast cancer women outcomes (i.e. does the presence of a research activity in a hospital improve certain outcomes vs. hospital without a significant research activity?). CCIb highlighted that it is not sure that a PICO question like this will retrieve a sufficient number of suitable studies, but as the group agreed on the relevance of the question a tentative will be made. Page: 2 of 5
3 The subgroup also raised issues on research at a general level (e.g. how women are informed, informed consent, etc.). The European QA scheme's requirements are discussed and selected via Delphi rounds. The will investigate with IQ Healthcare a way to have such requirements discussed in one of the planning rounds. Action points Action Timeline Who Raise the issue of special accreditation of high specialisation tests within the Testing subgroup Investigate with IQ Healthcare the feasibility of the discussion of research questions in Delphi rounds Investigate with CCIb the feasibility of a PICO question on research Provide a list with "special/rare breast cancer cases" for which it may be acceptable a referral to an expert/ second level centre As soon as a new version of the list of pathology testing for the European QA scheme is distributed to the subgroup January 2017 January 2017 End of January 2017 Giorgio Stanta Giorgio Stanta Page: 3 of 5
4 ANNEX I: List of participants NAME SURNAME David RIGAU CCIb Luigi CATALIOTTI Silvia Nadya Daniele Paolo Vitor Francesco Giorgio Maggie DEANDREA DIMITROVA GENERALI GIORGI ROSSI RODRIGUES SARDANELLI STANTA WILCOX GDG Page: 4 of 5
5 ANNEX II Meetings Notes - Teleconference between and Giorgio Stanta, Paolo Giorgi Rossi, Annette Lebeau and Cecily Quinn (8 November 2016) During the teleconference it was discussed: 1. The possibility that some breast lesions (B3) and/or breast cancer subtypes may need further research, or may benefit from services or treatment offered by centers with particular expertise in clinical research, bioinformatics, etc. 2. If this implies the need of a second level network of services offering this kind of facilities is still an open issue, also depending on the organisation of care in a specific country, the resources available, etc. It has been agreed that a systematic review aimed at identifying the cases falling under point 1. would form the basis for any future discussion. Therefore, the next Clinical Research Subgroup meeting will have as a goal the definition of this systematic review. Paolo gave his availability to attend that meeting, while Annette and Cecily will be engaged with the Testing -Pathology meeting. The will brief CCIb in advance, so that someone from their team can come to the meeting and help to define the systematic review's specifications. Page: 5 of 5
Quality Assurance Scheme Development Group Robert MANSEL
Quality Assurance Scheme Development Group Robert MANSEL Chair Disclaimer: The contents of this presentation are the views of the author and do not necessarily represent an official position of the European
More informationEuropean Commission Initiative on Breast Cancer (ECIBC) MEETING OF MONITORING SUBGROUP Ispra, 14 September 2016 (10:00-17:00) Minutes
EUROPEAN COMMISSION DIRECTORATE GENERAL JOINT RESEARCH CENTRE Directorate F Health, Consumers and Reference Materials Unit F1 Health in Society European Commission Initiative on Breast Cancer (ECIBC) MEETING
More informationthe EUROPEAN COMMISSION INITIATIVE
ECIBC the EUROPEAN COMMISSION INITIATIVE on BREAST CANCER Livia Giordano GDG Member CPO Piemonte - ITALY Origin of the Initiative Because of "substantial and persistent inequalities in breast cancer incidence,
More informationECIBC overview. Donata LERDA Healthcare Quality Team leader
ECIBC overview Donata LERDA Healthcare Quality Team leader Joint Research Centre Institute for Health and Consumer Protection Public Health Policy Support Disclaimer: The contents of this presentation
More informationOECI EUROPEAN MISSION WORKING PARTY: B&MP VIEW
BIOBANKING AND MOLECULAR PATHOBIOLOGY WG OECI EUROPEAN MISSION WORKING PARTY: B&MP VIEW Bruxelles 3 October 2018 Marco Pierotti & Giorgio Stanta CANCER AT MOLECULAR LEVEL STATEMENT 1 : Cancer is a disease
More informationA European Quality Assurance Scheme for Breast Cancer Services - updates Joint Research Centre
A European Quality Assurance Scheme for Breast Cancer Services - updates Joint Research Centre Institute for Health and Consumer Protection Public Health Policy Support Donata LERDA Disclaimer: The contents
More informationECIBC the EUROPEAN COMMISSION INITIATIVE on BREAST CANCER. Livia Giordano GDG Member CPO Piemonte - ITALY
ECIBC the EUROPEAN COMMISSION INITIATIVE on BREAST CANCER Livia Giordano GDG Member CPO Piemonte - ITALY Origin of the Initiative Because of "substantial and persistent inequalities in breast cancer incidence,
More informationEUROPA DONNA Advocates Guide to the ECIBC European Commission Initiative on Breast Cancer
EUROPA DONNA Advocates Guide to the ECIBC European Commission Initiative on Breast Cancer Part 1 About EUROPA DONNA EUROPA DONNA The European Breast Cancer Coalition is an independent non-profit organisation
More information3 rd GDG Meeting March Varese
3 rd GDG Meeting 15-16 March Varese Joint Research Centre Institute for Health and Consumer Protection Public Health Policy Support Zuleika SAZ PARKINSON Disclaimer: The contents of this presentation are
More informationThe European Commission Initiative on Breast Cancer (ECIBC): Plenary 2015
JRC CONFERENCE AND WORKSHOP REPORTS The European Commission Initiative on Breast Cancer (ECIBC): Plenary 2015 Improving breast cancer screening, diagnosis and care in Europe 9-11 December 2015, Baveno,
More informationSpecialised Services - Standards and Quality
Specialised Services - Standards and Quality Clinical Assurance Aim: to seek to provide assurance that the products of commissioning have clinical support from as broad a range of sectors and services
More informationNICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica
NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica Steven Vogel Vice Principal (Research), The British School of Osteopathy Editor-in-Chief, The
More informationThe 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer
The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer Conference "Putting Science into Standards" Ispra 20-21 October 2015 Michael Hübel, Head of Unit - Programme
More informationPOLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan
POLICY BRIEFING Prime Minister s challenge on dementia 2020 implementation plan Date: 14th March 2016 Author: Christine Heron LGiU associate Summary The Prime Minister s challenge on dementia contains
More informationParma, 21/09/2015 SCIENTIFIC EVALUATION OF REGULATED PRODUCTS DEPARTMENT
SCIENTIFIC EVALUATION OF REGULATED PRODUCTS DEPARTMENT Parma, 21/09/2015 Note on the establishment of a Standing Working Group on Dietary Reference Values for vitamins of the Scientific on Dietetic Products,
More informationGuidelines Platform Update
Guidelines Platform Update Liisa Pylkkanen Healthcare Quality Team Joint Research Centre the European Commission's in-house science service JRC Science Hub: ec.europa.eu/jrc The Guidelines Platform will
More informationImplementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges
Implementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges Frédérique Nowak - 21 october 2015 "Putting Science into Standards event:
More informationEFSA cross-cutting guidance lifecycle. European Food Safety Authority (EFSA), Daniela Maurici, Raquel Garcia Matas, Andrea Gervelmeyer
TECHNICAL REPORT APPROVED: 29 June 2018 doi:10.2903/sp.efsa.2018.en-1446 Abstract EFSA cross-cutting guidance lifecycle European Food Safety Authority (EFSA), Daniela Maurici, Raquel Garcia Matas, Andrea
More informationSupplementary Online Content
Supplementary Online Content Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. doi:10.1001/jama.2015.12783.
More informationFrom Better to Best: Improving the availability of organs for transplant
From Better to Best: Improving the availability of organs for transplant Elisabeth Buggins CBE Strategy Oversight Group Chair Presentation outline Progress 2004-2014 Strategy and work underway Outcomes
More informationNational Cancer Peer Review Programme. Radiotherapy Service Evidence Guide
National Cancer Peer Review Programme Radiotherapy Service Evidence Guide Forward This evidence guide has been formulated to assist organisations in preparing for peer review. The contents of this guide
More informationJune 15, David Marquis Department of Health Three Capitol Hill Providence, RI Dear Mr.
RI Commission on the Deaf and Hard of Hearing Draft Letter #1 June 15, 2017 David Marquis Department of Health Three Capitol Hill Providence, RI 02908 David.Marquis@health.ri.gov Dear Mr. Marquis, provides
More informationEUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 10 FEBRUARY 2015
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Brussels sante.ddg2.g.dir(2015)934853 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 10 FEBRUARY
More informationEurydice activities in the field of Early Childhood Education and Care (KD ECEC 2014)
Eurydice activities in the field of Early Childhood Education and Care (KD ECEC 2014) Daniela Kocanova Education, Audiovisual and Culture Executive Agency (EACEA), Eurydice 12 th meeting of the OECD Network
More informationStandard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes
Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP
More informationVersion 1 February Patient and public involvement (PPI) in research groups. Guidance for Chairs
Version 1 February 2010 Patient and public involvement (PPI) in research groups Guidance for Chairs Foreword As a doctor and researcher, I chair a number of research groups which include patients and members
More informationCountry Delegates Workshop March, 2013 Overview of existing breast cancer screening guidelines
Country Delegates Workshop 13-14 March, 2013 Overview of existing breast cancer screening guidelines Federici Antonio Ministry of Health- Italy AGENDA THE STUDY (Quality appraisal of of guidelines for
More informationUK National Screening Committee. Screening for Stomach Cancer. 12 February 2016
14/397 UK National Screening Committee Screening for Stomach Cancer 12 February 2016 Aim 1. To ask the UK National Screening Committee to make a recommendation, based upon the evidence presented in this
More informationRoyal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010
Guidance producer: Royal College of Radiologists (RCR) Guidance product: Referral guidelines Date: 29 June 2010 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Implementation...
More informationNew Payments Architecture Design Hub. Payments Strategy Forum 30th January 2017
New Payments Architecture Design Hub Payments Strategy Forum 30th January 2017 Summary The NPA Design Hub has been established to progress the detailed design of the NPA before handover to the NPSO. Our
More informationBrighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer
Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationWhen in doubt, ask an expert
When in doubt, ask an expert MARC BEISHON No pathologist can be an expert in every type of cancer. But there is a lot that can be done to greatly improve the accuracy of diagnoses, particularly in rare
More informationANAEMIA MANAGEMENT: HOW AND WHY DOES ERBP DIFFER FROM KDIGO Francesco Locatelli, Lecco, Italy
ANAEMIA MANAGEMENT: HOW AND WHY DOES ERBP DIFFER FROM KDIGO Francesco Locatelli, Lecco, Italy Chair: Kai- Uwe Eckardt, Erlangen, Germany Pierre- Yves Martin, Geneva, Switzerland Prof. Francesco Locatelli
More informationDumfries and Galloway Alcohol and Drug Partnership. Strategy
Dumfries and Galloway Alcohol and Drug Partnership Strategy 2017 2020 1 Contents Foreword...3 1. Introduction... 4 1.1 Background... 4 1.2 Aim... 4 1.3 National Context... 4 2. Strategic Priorities...
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk
More informationInitiative on Breast Cancer
European Commission Initiative on Breast Cancer Plenary of the ECIBC Improving breast cancer screening, diagnosis and care in Europe Baveno, Lago Maggiore, Italy 9-11 December 2015 Contents Introduction
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationREVISED DRAFT STRATEGY ON UNESCO s CONTRIBUTION TO THE PROMOTION OF OPEN ACCESS TO SCIENTIFIC INFORMATION AND RESEARCH OUTLINE
36 C 36 C/62 20 October 2011 Original: English Item 5.26 of the provisional agenda REVISED DRAFT STRATEGY ON UNESCO s CONTRIBUTION TO THE PROMOTION OF OPEN ACCESS TO SCIENTIFIC INFORMATION AND RESEARCH
More informationHow Italy and France take on rare sarcoma cancers
Page 4 of 12 Road safety road transport Trucks and CO2 1. Home 2. News 3. Health 4. How Italy and France take on rare sarcoma cancers How Italy and France take on rare sarcoma cancers By Hannah Black and
More informationREPORT OF THE TECHNICAL MEETING: THE NEW DOSE LIMIT FOR THE LENS OF THE EYE IMPLICATIONS AND IMPLEMENTATION VIENNA, 2-4 OCTOBER 2012
REPORT OF THE TECHNICAL MEETING: THE NEW DOSE LIMIT FOR THE LENS OF THE EYE IMPLICATIONS AND IMPLEMENTATION VIENNA, 2-4 OCTOBER 2012 Introduction A Technical Meeting on the The new dose limit for the lens
More informationFinal Accreditation Report
Guidance producer: Uveal Melanoma Guideline Development Group Guidance product: Uveal Melanoma National Guidelines Date: 24 November 2014 Version: 1.3 Final Accreditation Report Uveal Melanoma Guideline
More informationOnline Form. Welcome to the Integrated Research Application System. IRAS Project Filter
Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system
More informationEUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.ddg2.g.dir(2015)2952292 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015
More informationi-thrive Academy Risk Support
i-thrive Academy Risk Support The i-thrive Academy is funded by Health Education England and delivered by the i-thrive Partnership. Four learning and development modules were piloted across three sites
More informationDCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018
DCP Newsletter Issue 1 June 2018 Welcome Hello and a warm welcome to all of our readers of this first edition of the Dorset Cancer Partnership (DCP) newsletter. Each edition of this newsletter will provide
More informationSTANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 15 July 2009
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 15 July 2009 Chairman: Mr Basil
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationPort of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter
Port of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter Charter Purpose The purpose of this charter is to define the role of the Planning Advisory Committee () within
More informationBritish Fertility Society. Clinical guidelines
Guidance producer: British Fertility Society Guidance Product: Clinical guidelines Date: 13 January 2011 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Reapplication
More informationAnnotations to the provisional agenda
Technology Executive Committee 29 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Annotations to the provisional agenda 1. Opening of the meeting 1. The Chair of the Technology Executive
More informationSpecific Challenges for Orphan Drugs with Paediatric Development
Specific Challenges for Orphan Drugs with Paediatric Development Tsveta Schyns-Liharska, PhD ENRAH Member of the PDCO, EMA Representing Patients and EURORDIS Disclaimer Some of the slides in this presentation
More informationDental Therapist Project
Dental Therapist Project Jan Curry In 2007 Dental Health Services Victoria (DHSV) undertook a project in which Dental Therapists (DTs) provided direct restorative care to adults older than 25 years under
More informationEuropean Medicines Agency decision
EMA/802543/2012 European Medicines Agency decision P/0293/2012 of 18 December 2012 on the acceptance of a modification of an agreed paediatric investigation plan for prucalopride (Resolor), (EMEA-000459-PIP01-08-M02)
More informationAppendix B: Planning Process
HILLSBOROUGH COUNTY POST-DISASTER REDEVELOPMENT PLAN B-1 Appendix B: Planning Process The Hillsborough County Post Disaster Redevelopment Plan (PDRP) is a community plan that was developed over the course
More informationQA Processes. Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013
QA Processes Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013 Standards QA visits Dashboards BCSP standards Standards for Organisation Service delivery Reporting Data quality Audit and
More informationUpdate on public hearing
Update on public hearing PCWP/HCPWP joint meeting Presented by Juan Garcia Burgos on 0 September 017 Head of Public Engagement Department An agency of the European Union A public hearing provides An opportunity
More informationGuidelines for the appointment of. General Practitioners with Special Interests in the Delivery of Clinical Services. Epilepsy
Guidelines for the appointment of General Practitioners with Special Interests in the Delivery of Clinical Services Epilepsy April 2003 Epilepsy This general practitioner with special interest (GPwSI)
More informationWaiting Times for Suspected and Diagnosed Cancer Patients
Waiting Times for Suspected and Diagnosed Cancer Patients 2015-16 Annual Report Waiting Times for Suspected and Diagnosed Cancer Patients 1 Waiting Times for Suspected and Diagnosed Cancer Patients Prepared
More informationThe European Medicines Agency (EMA)
The European Medicines Agency (EMA) Nathalie Bere Patient Relations Public Engagement Department EMA Training Day 29 November, 2016 An agency of the European Union What is the European Medicines Agency
More informationStatus Update on the Review of DMFs
Status Update on the Review of DMFs Presented by Dave Skanchy, Ph.D. Director DMF Review Staff GPhA/FDA CMC Workshop June 4, 2013 1 Outline Changes to the DMF Review Staff: Update on GDUFA hiring and the
More informationSTANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 30 April 2012 Chairmen: Mr Basil
More informationUK Council on Deafness Access to Work Group
UK Council on Deafness Access to Work Group Meeting 28 October 2014 Minutes In attendance Christine Archer, ANP Dan Sumners, Signature (minutes) David Buxton, BDA (chair) Frances Dobson, ALS Gail Dixon,
More informationThe EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,
The EU PIP - a step in Pediatric Drug Development Thomas Severin Bonn, 13.01.2009 Agenda Implications for Industry Company Preparation Time of PIP Submission Content of the PIP The PIP Process and first
More informationAnnual Report. Public Health Screening Programmes TO 31 MARCH Extract: Chapter 3 : Planning for Bowel Screening Programme
Public Health Screening Programmes Annual Report TO 31 MARCH 2007 Extract: Chapter 3 : Planning for Bowel Screening Programme Version 1.0 Published: 18 December 2007 1 Contents INTRODUCTION...3 SUMMARY...5
More informationResponse to: Concept paper of 9 February 2011 submitted for public consultation by the European Commission on the
Response to: Concept paper of 9 February 2011 submitted for public consultation by the European Commission on the REVISION OF THE CLINICAL TRIALS DIRECTIVE 2001/20/EC Submitted by the European AIDS Treatment
More informationPGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne
Public consultation on Delegated Act on Post-Authorisation efficacy studies PGEU RESPONSE INTRODUCTION The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists
More informationSMOKING OUTSIDE HOSPITALS: AN OPPORTUNITY TO COMMENT ON PROPOSALS
Population Health Directorate Health Improvement Division T: 0131-244 1707 E: elaine.mitchell@gov.scot Monday, 28 November, 2016 Dear Chief Executive, SMOKING OUTSIDE HOSPITALS: AN OPPORTUNITY TO COMMENT
More informationDevon Local Pharmaceutical Committee. Meeting held on 6 th January Westbank Centre, Exminster
Devon Local Pharmaceutical Committee Meeting held on 6 th January 2015 Westbank Centre, Exminster Present: David Bearman, Chris Babbs, Sadik Al- Hassan, Nerys Cadvan-Jones, David Chapman, David Fulton,
More informationDo you find this clinical policy or service specification clear and comprehensive?
Service specification for HIV: British HIV Association response Version 3 25012013 Do you find this clinical policy or service specification clear and comprehensive? No. There are a number of areas that
More informationNational Group for Volunteering in NHS Scotland
National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 15 November 2016 Crammond Room, Scottish Health Services Centre, Edinburgh. Present Neil Galbraith Alan Bigham Rob
More informationDraft Accreditation Report for consultation
Guidance producer: Duchenne Muscular Dystrophy Care Considerations Working Group Guidance product: Diagnosis and Management of Duchenne Muscular Dystrophy guideline Date: 24 June 2011 Draft Accreditation
More informationHeld on , Parma. (Agreed on )
AHAW UNIT SCIENTIFIC PANEL ON ANIMAL HEALTH AND WELFARE Minutes of the 10 th meeting of the Working Group on possible risks posed by the Influenza A (H3N2v) virus for animal health and its potential spread
More informationFrom the Permanent Secretary and HSC Chief Executive
From the Permanent Secretary and HSC Chief Executive Dr Andrew Murrison MP Chair, N. Ireland Affairs Committee Committee Office House of Commons LONDON SW1A 0AA northircom@parliament.uk Castle Buildings
More informationEUROPEAN MEDICINES AGENCY DECISION. of 24 June 2008
European Medicines Agency Doc. Ref. EMEA/310181/2008 P/32/2008 EUROPEAN MEDICINES AGENCY DECISION of 24 June 2008 on the application for agreement of a Paediatric Investigation Plan for zoledronic acid
More informationPeer counselling A new element in the ET2020 toolbox
shutterstock Peer counselling A new element in the ET2020 toolbox Information Note. Main characteristics of the peer counselling tool Peer learning in the context of the education cooperation at EU level
More information13 th Meeting Forensic Science Technical Advisory Committee (FSTAC)
13 th Meeting Forensic Science Technical Advisory Committee (FSTAC) Head Office 2 Pine Trees, Chertsey Lane, Staines- Upon-Thames, TW18 3HR Thursday 30 th November 2017 11:15am 3.00pm Minutes Attendees
More informationUnderstanding How the U.S. Preventive Services Task Force Works USPSTF 101
Understanding How the U.S. Preventive Services Task Force Works USPSTF 101 1 2 Goals Improve understanding of the U.S. Preventive Services Task Force (USPSTF or Task Force) Explain the connection between
More informationIPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope
IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human
More informationReflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford
Reflections on NICE Headache Guideline Dr Kay Kennis GPwSI in Headache, Bradford Overview The process of guideline development illustrated with the headache guideline Reflections on the process Key recommendations
More informationFRAILTY PATIENT FOCUS GROUP
FRAILTY PATIENT FOCUS GROUP Community House, Bromley 28 November 2016-10am to 12noon In attendance: 7 Patient and Healthwatch representatives: 4 CCG representatives: Dr Ruchira Paranjape went through the
More informationCancer Awareness & Early Diagnosis Project Examples. Location: Camden (intervention area) and Kensington & Chelsea (control area), London
PROJECT TITLE: Improving breast awareness in women aged 45-54 Location: Camden (intervention area) and Kensington & Chelsea (control area), London PROJECT DETAILS Problem addressed: Breast cancer is now
More informationHaematology Regional Group Meeting Monday 18 th October 2010, Antrim Hospital
Haematology Regional Group Meeting Monday 18 th October 2010, Antrim Hospital In attendance: Dr Anne Kyle Clinical Lead Ms Sarah Taggart Ms Caroline McCaughey Ms Margaret Michael Dr Robert Cuthbert Ms
More informationWorkshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation
Dr. Anja Holm Chair of CVMP, EMA Danish Medicines Agency Copenhagen, DK - Denmark anh@dkma.dk Overview of existing structures relevant for Veterinary Products Regional Structures: Europe European Medicine
More informationVersion 2 of these Guidelines were drafted in response to published updated ASCO/CAP HER2 test Guideline Recommendations-
Introduction: These guidelines represent systematically developed statements to assist in the provision of quality assured HER2 testing in breast and gastric/ gastro-oesophageal carcinoma. They are based
More informationThank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS.
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More information6 th EFC Satellite meeting, Saturday 1 st December 2018
6 th EFC Satellite meeting, Saturday 1 st December 2018 Introduction Pekka Nieminen President-elect of the European Federation for Colposcopy, Department of Obstetrics and Gynaecology, Helsinki University
More informationWhat does an NCD Do? ARMA Lecture 26th November 2013
What does an NCD Do? ARMA Lecture 26th November 2013 Low Back Pain in the New NHS Charles Greenough National Clinical Director for Spinal Services New Medical Directorate Sir Bruce Keogh Medical Director
More informationResponding Effectively to BPD Challenges for the Service System. Katerina Volny Peter McKenzie
Responding Effectively to BPD Challenges for the Service System Katerina Volny Peter McKenzie Borderline Personality Disorder A common mental illness characterised by poor control of emotions and impulses,
More informationSpecial guidelines for preparation and quality approval of reviews in the form of reference documents in the field of occupational diseases
Special guidelines for preparation and quality approval of reviews in the form of reference documents in the field of occupational diseases November 2010 (1 st July 2016: The National Board of Industrial
More informationKey Ethical Issues in a Multicultural Society
Key Ethical Issues in a Multicultural Society Professor Gurch Randhawa Director, Institute for Health Research University of Bedfordshire gurch.randhawa@beds.ac.uk Inequalities of Access Ethnic Minority
More informationFit4RareFit4All Conference Cluj - Napoca 3-4 September 2017
Fit4RareFit4All Conference Cluj - Napoca 3-4 September 2017 Rare diseases registries as key tools in research and public health Domenica Taruscio Director, National Centre for Rare Diseases Istituto Superiore
More informationDRAFT VERSION I SAFEGUARDING CHILDRENS BOARD MARCH 2017 SOUTHWARK PREVENT DRAFT LOCAL DELIVERY PLAN Page 1
SAFEGUARDING CHILDRENS BOARD MARCH 017 SOUTHWARK PREVENT DRAFT LOCAL DELIVERY PLAN 017-019 Page 1 STRATEGIC OBJECTIVES 1 SUPPORT FOR COMMUNITIES Engagement with communities and voluntary/faith institutions
More informationEvaluation of the computer-based CBT programme pilot at rural community pharmacies in Gwynedd
Evaluation of the computer-based CBT programme pilot at rural community pharmacies in Gwynedd Authors: Gareth Holyfield (Principal Pharmacist, Public Health Wales) Steffan John (Community Pharmacist, Betsi
More informationGMS Contract in Wales Enhanced Service for Homeless Patients Specification
Doc 4 GMS Contract in Wales 2008-09 Enhanced Service for Homeless Patients Specification Introduction The purpose of this paper is to provide an enhanced service specification for Local Health Boards when
More informationPerspective on performance: The Haemoglobinopathies. Barbara Wild
Perspective on performance: The Haemoglobinopathies Barbara Wild Perspective on Performance: Performance assessment process DNA diagnostics for Haemoglobinopathies scheme Outcomes of shadow scoring exercise
More informationCanadian Task Force on Preventive Health Care ~ Public Record of Meeting June 12 & 13, 2017, Best Western Plus Downtown Suites, Ottawa
Canadian Task Force on Preventive Health Care ~ Public Record of Meeting June 12 & 13, 2017, Best Western Plus Downtown Suites, Ottawa CTFPHC Chairs: Marcello Tonelli (Chair) Brett Thombs (Chair-Elect)
More informationMedia pack for secondary breast cancer campaigners
Media pack for secondary breast cancer campaigners Introduction Are you one of Breast Cancer Care s amazing campaigners? Would you be keen to share your story with local newspapers and radio stations to
More informationSkull Base Tumour Service. The Multi-Disciplinary Team (MDT) Explained. Jan 2018 v1
Skull Base Tumour Service The Multi-Disciplinary Team (MDT) Explained Jan 2018 v1 Skull base tumours grow in the bones of the skull that form the bottom of the head and the body ridge between the nose
More informationAction plan for improving the peer review process. European Food Safety Authority (EFSA)
TECHNICAL REPORT APPROVED: 29 November 2017 doi:10.2903/sp.efsa.2017.en-1349 Action plan for improving the peer review process European Food Safety Authority (EFSA) Abstract This document reflects on the
More information